general manager of Abbott's UK and Ireland diabetes care business. In clinical trials, use of the Freestyle Libre CGM range has been shown to improve blood glucose control, reducing hypoglycaemic ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

Canadians living with type 2 diabetes can feel anxious and overwhelmed due to the constant demands of managing their condition, alongside everyday responsibilities. The diabetes experience is one that ...

Abbott's FreeStyle Libre 2 and 3 continuous glucose monitors no longer need to be removed for imaging tests. CGM readings during an MRI may be affected for up to an hour after the procedure. While ...

胰岛素输送和糖尿病技术领先企业Tandem Diabetes Care, Inc. (TNDM)在2024年第三季度财报电话会议上报告了公司历史上最高的季度销售额。总裁兼首席执行官John ...

Abbott Diabetes Care was created in 2004 with the acquisition of TheraSense Inc., a leading blood glucose monitoring business. The diagnostics portfolio was expanded with the addition of i-STAT Corp., ...

FreeStyle Libre 2 sensors will be phased out in the UK by the end of August 2025, meaning that people living with diabetes who use the sensors will need to transition to using FreeStyle Libre 2 Plus ...

Oct. 31, 2024 — Children who experienced sugar restrictions during their first 1,000 days after conception had up to 35% lower risk of developing type 2 diabetes and as much as 20% less risk of ...